1-3 of 3
Mollie E. Moran, MSN
Close
Sort by
Journal Articles

Flavopiridol, Fludarabine and Rituximab (FFR): An Active Regimen in Indolent B-Cell Lymphoproliferative Disorders and Mantle Cell Lymphoma.

Thomas S. Lin, MD, PhD, Beth Fischer, BSN, RN, Kristie A. Blum, MD, Pierluigi Porcu, MD, Eric H. Kraut, MD, Robert A. Baiocchi, MD, PhD, Mollie E. Moran, MSN, CNP, Sarah Mitchell, Michael R. Grever, MD, John C. Byrd, MD
Journal: Blood
Blood (2008) 112 (11): 1571.
https://doi.org/10.1182/blood.V112.11.1571.1571
Published: 2008
Journal Articles

Flavopiridol (Alvocidib) Induces Durable Responses in Relapsed Chronic Lymphocytic Leukemia (CLL) Patients with High-Risk Cytogenetic Abnormalities

Thomas S. Lin, MD, PhD, Nyla A. Heerema, PhD, Gerard Lozanski, MD, Beth Fischer, BSN, RN, Kristie A. Blum, MD, Leslie A. Andritsos, MD, Jeffrey A. Jones, MD, Joseph M. Flynn, DO, MPH, Mollie E. Moran, MSN, CNP, Sarah Mitchell, Amy J. Johnson, PhD, Mitch A. Phelps, PhD, Michael R. Grever, MD, John C. Byrd, MD
Journal: Blood
Blood (2008) 112 (11): 46.
https://doi.org/10.1182/blood.V112.11.46.46
Published: 2008
Journal Articles

Successful Management (Mgt) of Hyperkalemia Associated with Tumor Lysis Syndrome (TLS) in Refractory Chronic Lymphocytic Leukemia (CLL) Patients (pts) Receiving Flavopiridol on an Active Pharmacologically Derived Schedule.

Mollie E. Moran, MSN, Beth Fischer, MSN, Sara Broering, BS, Kristie A. Blum, MD, Thomas S. Lin, MD, PhD, John C. Byrd, MD, Michael R. Grever, MD, Michelle Brooker-McEldowney, MSN
Journal: Blood
Blood (2005) 106 (11): 2124.
https://doi.org/10.1182/blood.V106.11.2124.2124
Published: 2005